Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quality Assessment of Tracheal Intubation Without Neuromuscular Blocking Drugs in Obese Patients (Propofol + Remifentanil): Pilot Study
2021-000727-12Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- May 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remifentanil and propofol in None (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: percentage of patients with excellent orotracheal intubation conditions. Started May 2021; status: completed.
02
Drugs
remifentanilpropofol
Beyond the preview
Go deeper on 2021-000727-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000727-12.